Relationships among lactate concentration, blood flow and histopathologic profiles in rat C6 glioma

M. Terpstra, W. B. High, Y. Luo, R. A. De Graaf, H. Merkle, M. Garwood

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Increased capacity for glycolytic metabolism is a well-known characteristic of neoplastic cells. Because lactic acid is the end product of glycolysis, in vive MRS measurements of tumor lactate concentration ([lac]1) may provide valuable information about tumor metabolism, which will aid the development of therapies and the clinical diagnosis and treatment of tumors. In the present study, several hemodynamic and histologic parameters were evaluated with respect to their influence on [lac](t). Pronounced differences in [lac](t) in two distinct populations of tumors suggested a putative perfusion threshold. Above this threshold, [lac](t), was independent of hemodynamic and histologic factors including tumor blood flow (measured using MRS and the method of D2O washout), extent of necrosis and inflammatory cell infiltrate. Thus, for most tumors, [lac](t) was not determined by any one single factor such as hypoxia, venous clearance, glucose supply, extent of necrosis or degree of inflammatory cell infiltrate. Rather, [lac](t) may be equilibrated, at least in part, by an interplay of forces involving hemodynamics and substrate supply. In general, the data are consistent with the hypothesis that elevated lactate in most tumors is related to the high glycolytic activity of adequately perfused, viable neoplastic cells.

Original languageEnglish (US)
Pages (from-to)185-194
Number of pages10
JournalNMR in biomedicine
Volume9
Issue number5
DOIs
StatePublished - Aug 1 1996

Fingerprint

Glioma
Rats
Lactic Acid
Blood
Tumors
Hemodynamics
Neoplasms
Metabolism
Necrosis
Glycolysis
Perfusion
Glucose
Substrates
Population

Cite this

Relationships among lactate concentration, blood flow and histopathologic profiles in rat C6 glioma. / Terpstra, M.; High, W. B.; Luo, Y.; De Graaf, R. A.; Merkle, H.; Garwood, M.

In: NMR in biomedicine, Vol. 9, No. 5, 01.08.1996, p. 185-194.

Research output: Contribution to journalArticle

Terpstra, M. ; High, W. B. ; Luo, Y. ; De Graaf, R. A. ; Merkle, H. ; Garwood, M. / Relationships among lactate concentration, blood flow and histopathologic profiles in rat C6 glioma. In: NMR in biomedicine. 1996 ; Vol. 9, No. 5. pp. 185-194.
@article{5c51474de24d43b9a9051188cc37e646,
title = "Relationships among lactate concentration, blood flow and histopathologic profiles in rat C6 glioma",
abstract = "Increased capacity for glycolytic metabolism is a well-known characteristic of neoplastic cells. Because lactic acid is the end product of glycolysis, in vive MRS measurements of tumor lactate concentration ([lac]1) may provide valuable information about tumor metabolism, which will aid the development of therapies and the clinical diagnosis and treatment of tumors. In the present study, several hemodynamic and histologic parameters were evaluated with respect to their influence on [lac](t). Pronounced differences in [lac](t) in two distinct populations of tumors suggested a putative perfusion threshold. Above this threshold, [lac](t), was independent of hemodynamic and histologic factors including tumor blood flow (measured using MRS and the method of D2O washout), extent of necrosis and inflammatory cell infiltrate. Thus, for most tumors, [lac](t) was not determined by any one single factor such as hypoxia, venous clearance, glucose supply, extent of necrosis or degree of inflammatory cell infiltrate. Rather, [lac](t) may be equilibrated, at least in part, by an interplay of forces involving hemodynamics and substrate supply. In general, the data are consistent with the hypothesis that elevated lactate in most tumors is related to the high glycolytic activity of adequately perfused, viable neoplastic cells.",
author = "M. Terpstra and High, {W. B.} and Y. Luo and {De Graaf}, {R. A.} and H. Merkle and M. Garwood",
year = "1996",
month = "8",
day = "1",
doi = "10.1002/(SICI)1099-1492(199608)9:5<185::AID-NBM414>3.0.CO;2-X",
language = "English (US)",
volume = "9",
pages = "185--194",
journal = "NMR in Biomedicine",
issn = "0952-3480",
publisher = "John Wiley and Sons Ltd",
number = "5",

}

TY - JOUR

T1 - Relationships among lactate concentration, blood flow and histopathologic profiles in rat C6 glioma

AU - Terpstra, M.

AU - High, W. B.

AU - Luo, Y.

AU - De Graaf, R. A.

AU - Merkle, H.

AU - Garwood, M.

PY - 1996/8/1

Y1 - 1996/8/1

N2 - Increased capacity for glycolytic metabolism is a well-known characteristic of neoplastic cells. Because lactic acid is the end product of glycolysis, in vive MRS measurements of tumor lactate concentration ([lac]1) may provide valuable information about tumor metabolism, which will aid the development of therapies and the clinical diagnosis and treatment of tumors. In the present study, several hemodynamic and histologic parameters were evaluated with respect to their influence on [lac](t). Pronounced differences in [lac](t) in two distinct populations of tumors suggested a putative perfusion threshold. Above this threshold, [lac](t), was independent of hemodynamic and histologic factors including tumor blood flow (measured using MRS and the method of D2O washout), extent of necrosis and inflammatory cell infiltrate. Thus, for most tumors, [lac](t) was not determined by any one single factor such as hypoxia, venous clearance, glucose supply, extent of necrosis or degree of inflammatory cell infiltrate. Rather, [lac](t) may be equilibrated, at least in part, by an interplay of forces involving hemodynamics and substrate supply. In general, the data are consistent with the hypothesis that elevated lactate in most tumors is related to the high glycolytic activity of adequately perfused, viable neoplastic cells.

AB - Increased capacity for glycolytic metabolism is a well-known characteristic of neoplastic cells. Because lactic acid is the end product of glycolysis, in vive MRS measurements of tumor lactate concentration ([lac]1) may provide valuable information about tumor metabolism, which will aid the development of therapies and the clinical diagnosis and treatment of tumors. In the present study, several hemodynamic and histologic parameters were evaluated with respect to their influence on [lac](t). Pronounced differences in [lac](t) in two distinct populations of tumors suggested a putative perfusion threshold. Above this threshold, [lac](t), was independent of hemodynamic and histologic factors including tumor blood flow (measured using MRS and the method of D2O washout), extent of necrosis and inflammatory cell infiltrate. Thus, for most tumors, [lac](t) was not determined by any one single factor such as hypoxia, venous clearance, glucose supply, extent of necrosis or degree of inflammatory cell infiltrate. Rather, [lac](t) may be equilibrated, at least in part, by an interplay of forces involving hemodynamics and substrate supply. In general, the data are consistent with the hypothesis that elevated lactate in most tumors is related to the high glycolytic activity of adequately perfused, viable neoplastic cells.

UR - http://www.scopus.com/inward/record.url?scp=0030207099&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030207099&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1099-1492(199608)9:5<185::AID-NBM414>3.0.CO;2-X

DO - 10.1002/(SICI)1099-1492(199608)9:5<185::AID-NBM414>3.0.CO;2-X

M3 - Article

VL - 9

SP - 185

EP - 194

JO - NMR in Biomedicine

JF - NMR in Biomedicine

SN - 0952-3480

IS - 5

ER -